Suchergebnisse - "Bente L Langdahl"

PubPharm (9)

1

Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta

in: BMJ Open | 2023

von Jennifer Walsh | Catriona Keerie | Stuart H Ralston | +6

2

Bone Phenotyping Approaches in Human, Mice and Zebrafish – Expert Overview of the EU Cost Action GEMSTONE (“GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork”)

in: Frontiers in Endocrinology | 2021

von Ines Foessl | J. H. Duncan Bassett | Åshild Bjørnerem | +37

3

Skeletal responses to romosozumab after 12 months of denosumab

in: JBMR Plus | 2021

von Michael R. McClung | Michael A. Bolognese | Jacques P. Brown | +7

4

Diabetes and bone

in: Osteoporosis and Sarcopenia | 2019

von Katrine Hygum | Jakob Starup-Linde | Bente L. Langdahl

5

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

enthalten in: The lancet | 2017

von Bente L Langdahl | Cesar Libanati | Daria B Crittenden | +19

6

Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture

enthalten in: Nature | 2015

von Hou-Feng Zheng | Vincenzo Forgetta | Yi-Hsiang Hsu | +98

7

Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial.

in: PLoS ONE | 2012

von Thomas A Rasmussen | Danny Jensen | Martin Tolstrup | +6

8

Correction: Large-Scale Evidence for the Effect of the Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study.

in: PLoS Medicine | 2006

von Stuart H Ralston | André G Uitterlinden | Maria Luisa Brandi | +28

9

Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study.

in: PLoS Medicine | 2006

von Stuart H Ralston | André G Uitterlinden | Maria Luisa Brandi | +29

1
[1]